Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

EuroPCR 2025 | Individual Patient Data Meta-analysis of PROTECTED TAVR and BHF PROTECT-TAVI

Stroke remains a significant complication associated with the various transcatheter aortic valve implantation (TAVI) devices currently in use. The Sentinel cerebral embolic protection (CEP) device could capture embolic debris during TAVI procedures; however, randomized trials have so far failed to show a significant reduction in stroke incidence.

Two major studies were conducted: PROTECTED TAVR (3,000 patients, primarily from the U.S.) and BHF PROTECT-TAVI (7,635 patients from the U.K.), both evaluating stroke occurrence within 72 hours post-TAVI or at hospital discharge. In both trials, a non-significant reduction in neurovascular events was observed (-0.6%, p=0.30 and -0.02%, p=0.94, respectively).

Based on these data, researchers carried out a meta-analysis of individual patient data. A primary analysis assessed stroke incidence (within 72 hours or at discharge) between patients who received CEP and those who did not. A per-protocol analysis was also conducted, including only patients with both CEP filters correctly deployed.

Upon primary analysis, stroke incidence did not show significant differences. However, upon per-protocol analysis, the CEP group showed a lower stroke rate (2.3% vs. 1.7%; P=0.023), though not sustained after adjusting for confounding factors.

Read also: EuroPCR 2025 | Angiography- vs. Physiology-Guided PCI in TAVI Candidates (FAITAVI).

Regarding disabling stroke, the subgroup with proper positioning of both filters showed significantly lower incidence (1.3% vs. 0.8%; P=0.007) at per-protocol analysis.

The authors concluded that there is insufficient evidence to support the routine use of CEP to reduce stroke incidence. They emphasized the need to further identify high-risk subgroups that may benefit from this strategy.

Presented by R. Kharbanda during the Major Late Breaking Trials session, EuroPCR 2025, May 21, Paris, France.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

KISS Trial: provisional stenting in non-left main coronary bifurcations — is less more?

Coronary bifurcation angioplasty remains one of the most frequent and technically challenging scenarios in interventional cardiology. Between 15% and 20% of coronary procedures involve...

Complex radial access: a four-step protocol to overcome loops and tortuosity

Radial access is currently the preferred strategy for coronary angiography and percutaneous coronary interventions due to its lower rates of bleeding and vascular complications...

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...